SCHEMBL7873448

SCHEMBL7873448

NC(=O)c1cccnc1NC(=O)[CH]CCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
HTT P42858 2/20 0.48
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
KDM4E B2RXH2 4/20 0.47
LMNA P02545 3/20 0.47
GLA P06280 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ALDH1A1 P00352 5/20 0.47
HPGD P15428 3/20 0.47
HSD17B10 Q99714 1/20 0.47
RAB9A P51151 4/20 0.46
NPC1 O15118 3/20 0.46
AHR P35869 1/20 0.46
GAA P10253 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
RPS6KB1 P23443 1/20 0.42
DHODH Q02127 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7873394 0.79 ALDH1A1 (0.49) MAPTSMN1; SMN2HTTMEN1KMT2A
SCHEMBL7873416 0.79 ANPEP (0.49) MAPTSMN1; SMN2HTTKDM4ELMNA
SCHEMBL3716881 0.78 MAPT (0.70) MAPTSMN1; SMN2HTTMEN1KMT2A
SCHEMBL4952246 0.75 ACHE (0.41) MAPTSMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL20722727 0.74 KDM4E (0.62) MAPTSMN1; SMN2HTTMEN1KMT2A
SCHEMBL8554278 0.73 MAPT (0.46) MAPTSMN1; SMN2HTTMEN1KMT2A
SCHEMBL4949852 0.73 RAB9A (0.44) SMN1; SMN2MEN1KMT2AKDM4ELMNA
SCHEMBL3252093 0.72 PPIA (0.47) MAPTSMN1; SMN2HTTKDM4EALDH1A1
SCHEMBL7879245 0.72 RIOK2 (0.42) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL479805 0.72 DHODH (0.76) MAPTSMN1; SMN2HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US disclosed